A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...
A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player in prostate ...
It is a smart strategy to diversify your portfolio by investing in high-quality companies built on proven technologies.
Amazon S3 on MSN
How gene editing could reshape the future of humans
CRISPR technology could one day create “designer babies, ” raising major ethical and social inequality concerns.
13hon MSN
Tom Brady says he cloned his dog
Tom Brady's dog is a clone of a "beloved" pet that died, the seven-time Super Bowl champion revealed on Tuesday.
Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...
Meanwhile, ARK sold 15,362 shares of Roku Inc (NASDAQ:ROKU) through its ARKK ETF, totaling $1,668,774. This marks a continuation of ARK’s recent trend of reducing its holdings in the streaming ...
Smith, a microbiologist whose discovery revolutionize the field of genetic engineering, was a Johns Hopkins School of ...
A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
Bionova Scientific announced Thursday it would bring 200 new jobs to The Woodlands over the next several years, bolstering ...
Key market opportunities for Cas12 proteins include rising government investments in biotech, increased demand for ...
Azalea's first drug candidate is a CAR-T therapy for cancer and autoimmune conditions that turns immune cells into cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback